270 filings
8-K
BPTH
Bio-Path Holdings Inc
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
8-K
BPTH
Bio-Path Holdings Inc
3 Jun 24
Other Events
7:10am
8-K
BPTH
Bio-Path Holdings Inc
30 May 24
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
4:10pm
8-K
BPTH
Bio-Path Holdings Inc
15 May 24
Bio-Path Holdings Reports First Quarter 2024 Financial Results
7:10am
8-K
BPTH
Bio-Path Holdings Inc
19 Apr 24
Other Events
3:31pm
8-K
ovzjyc67wrgml
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
8-K
3yp8diunpnxd5pt1l0
18 Apr 24
Other Events
9:13am
8-K
eefq5aqivljthr
15 Apr 24
Bio-Path Holdings Expands Global Patent Portfolio
7:30am
8-K
onz7t60ahjj3kwwm5lh
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
8-K
bdomrwoqk0g qh
2 Apr 24
Bio-Path Holdings Provides 2024 Clinical and Operational Update
4:10pm
8-K
4zriwh4yx5nw9r
27 Mar 24
Other Events
8:20am
8-K
sokr0q
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
8-K
ini66m0o 2svf
13 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
0sk4pe8ma6p 8f764
11 Mar 24
Other Events
7:00am
8-K
7obl8mcz wclml89nw0
8 Mar 24
Bio-path Holdings Reports Full Year 2023 Financial Results
7:10am
8-K
opo991
23 Feb 24
Bio-Path Holdings Announces 1-for-20 Reverse Stock Split
7:01am
8-K
loqk7vkt0482bcarm
2 Feb 24
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
n6ti1cy2z15hyf9o j9
23 Jan 24
Submission of Matters to a Vote of Security Holders
5:20pm
8-K
218kxjgjm3m b6
10 Jan 24
Targeting Bcl-2 Protein Offers Potential Treatment for Patients Who Have Failed or Relapsed from Venetoclax-Based Frontline Therapy
4:10pm
8-K
gf3be2sw
15 Dec 23
Submission of Matters to a Vote of Security Holders
4:05pm